Phase IB/II study of second-line therapy with panitumumab, irinotecan, and everolimus (PIE) in KRAS wild-type metastatic colorectal cancer Academic Article uri icon

authors

  • Townsend, Amanda
  • Tebbutt, Niall
  • Karapetis, Christos
  • Cooper, Pamela
  • Singhal, Nimit
  • Yeend, Susan
  • Pirc, Louise
  • Joshi, Rohit
  • Hardingham, Jennifer
  • Price, Timothy

publication date

  • 2018